Search

everythinglearnresearchcommunity

for

Search:↓

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Truncated LTBP-1 disrupts TGF-beta signaling, affecting hair growth.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

Topical 0.1% tacrolimus improved a rare ear condition in cats.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

TCF7L2 gene polymorphism is linked to alopecia areata, but it doesn't affect the success of PRP or conventional treatments.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

A protein complex called mTORC1 likely affects when hair growth starts in mice.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Stem cells slowed lung tumor growth but increased colon tumor growth in mice.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Tight junctions create a barrier in pig hair follicles that controls what can enter the skin.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

A protein called COMP is part of the connective tissue in normal human hair follicles and may be important for hair health.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.